Multidisciplinary management of advanced prostate cancer: Changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trials

Michael A. Carducci; Peter R. Carroll; Matthew R. Smith; Robert S. DiPaola; Joel B. Nelson

doi:10.1016/j.urology.2005.03.044

Multidisciplinary management of advanced prostate cancer: Changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trials

Michael A. Carducci
, Peter R. Carroll
, Matthew R. Smith
, Robert S. DiPaola
, Joel B. Nelson

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

Prostate cancer traditionally was managed by monotherapy, and treatment was almost exclusively provided by the urologic surgeon. As ongoing clinical trials in advanced disease identify novel agents or combination therapies with good tolerability and potential survival benefits, multidisciplinary management may offer optimal care for men with high-risk prostate cancer, as it does for women with breast cancer. Patients with high-risk recurrent or metastatic disease should be informed of clinical trials for which they may be eligible.

Original language	English
Pages (from-to)	18-22
Number of pages	5
Journal	Urology
Volume	65
Issue number	5 SUPPL.
DOIs	https://doi.org/10.1016/j.urology.2005.03.044
State	Published - May 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.urology.2005.03.044

Cite this

@article{a0a2487d414f4eb8814af60bb07d0cb6,

title = "Multidisciplinary management of advanced prostate cancer: Changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trials",

abstract = "Prostate cancer traditionally was managed by monotherapy, and treatment was almost exclusively provided by the urologic surgeon. As ongoing clinical trials in advanced disease identify novel agents or combination therapies with good tolerability and potential survival benefits, multidisciplinary management may offer optimal care for men with high-risk prostate cancer, as it does for women with breast cancer. Patients with high-risk recurrent or metastatic disease should be informed of clinical trials for which they may be eligible.",

author = "Carducci, \{Michael A.\} and Carroll, \{Peter R.\} and Smith, \{Matthew R.\} and DiPaola, \{Robert S.\} and Nelson, \{Joel B.\}",

year = "2005",

month = may,

doi = "10.1016/j.urology.2005.03.044",

language = "English",

volume = "65",

pages = "18--22",

number = "5 SUPPL.",

}

Multidisciplinary management of advanced prostate cancer: Changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trials. / Carducci, Michael A.; Carroll, Peter R.; Smith, Matthew R. et al.
In: Urology, Vol. 65, No. 5 SUPPL., 05.2005, p. 18-22.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Multidisciplinary management of advanced prostate cancer

T2 - Changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trials

AU - Carducci, Michael A.

AU - Carroll, Peter R.

AU - Smith, Matthew R.

AU - DiPaola, Robert S.

AU - Nelson, Joel B.

PY - 2005/5

Y1 - 2005/5

N2 - Prostate cancer traditionally was managed by monotherapy, and treatment was almost exclusively provided by the urologic surgeon. As ongoing clinical trials in advanced disease identify novel agents or combination therapies with good tolerability and potential survival benefits, multidisciplinary management may offer optimal care for men with high-risk prostate cancer, as it does for women with breast cancer. Patients with high-risk recurrent or metastatic disease should be informed of clinical trials for which they may be eligible.

AB - Prostate cancer traditionally was managed by monotherapy, and treatment was almost exclusively provided by the urologic surgeon. As ongoing clinical trials in advanced disease identify novel agents or combination therapies with good tolerability and potential survival benefits, multidisciplinary management may offer optimal care for men with high-risk prostate cancer, as it does for women with breast cancer. Patients with high-risk recurrent or metastatic disease should be informed of clinical trials for which they may be eligible.

UR - https://www.scopus.com/pages/publications/18244410137

UR - https://www.scopus.com/pages/publications/18244410137#tab=citedBy

U2 - 10.1016/j.urology.2005.03.044

DO - 10.1016/j.urology.2005.03.044

M3 - Article

C2 - 15885275

AN - SCOPUS:18244410137

SN - 0090-4295

VL - 65

SP - 18

EP - 22

JO - Urology

JF - Urology

IS - 5 SUPPL.

ER -

Multidisciplinary management of advanced prostate cancer: Changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trials

Abstract

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this